CG
BIO icon

Curat Global’s Bio-Rad Laboratories Class A BIO Stock Holding History

Curat Global’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$52.9K Hold
140
– – 0.05% 170
2026
Q2 		$41.1K Hold
140
– – 0.03% 185
2026
Q1 		$39K Hold
140
– – 0.04% 184
2025
Q4 		$42.4K Hold
140
– – 0.05% 176
2025
Q3 		$39.3K Hold
140
– – 0.04% 188
2025
Q2 		$33.8K Hold
140
– – 0.03% 193
2025
Q1 		$34.1K Buy
+140
New +$42.1K 0.04% 200

Other funds holding BIO

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return
Hosking Partners
Hosking Partners London, United Kingdom $2.81B AUM 67.07% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
AL
Arnhold LLC New York $1.4B AUM 42.37% 1-Year Est. Return

Curat Global's BIO Position: Q3 2026 in Review

Curat Global held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2026 at 140 shares worth $52.9K. The position accounts for 0.05% of the portfolio, ranked #170.

Curat Global first reported a position in BIO in Q1 2025 and has held it in 7 quarters since. 180 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

  • Curat Global held 140 shares of Bio-Rad Laboratories Class A worth $52.9K as of Q3 2026.
  • Curat Global left its Bio-Rad Laboratories Class A share count unchanged in Q3 2026.
  • Bio-Rad Laboratories Class A made up 0.05% of Curat Global's portfolio in Q3 2026, its #170 holding.
  • Curat Global first reported a position in Bio-Rad Laboratories Class A in Q1 2025 and has held it in 7 quarters since.
  • 180 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on Curat Global's 13F filing for Q3 2026, filed 26 Oct 2026.